Raj Gerard Marshall, Priyadarshini Rekha, Mathaiyan Jayanthi
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605 006, India,
Eur J Clin Pharmacol. 2015 Apr;71(4):403-9. doi: 10.1007/s00228-015-1811-5. Epub 2015 Feb 3.
Inquisitive scientists are untiring and relentless in the hard work they perform day in and day out. In this pursuit, a researcher has to exercise their intellectual expertise in its entirety. Eventually, all credit of the invention is vested with the inventor who has the right of control over their intellectual creation. Likewise, pharmaceutical companies spend extravagantly in successfully introducing a novel drug from hundreds and thousands of lead compounds. Hence, it is a prerogative for every company to protect its innovative products from unauthorized duplication. Certainly, "patents" are the sole custodians of these products of medical intelligence - the drugs! This review focuses on the various intricacies of the drug patent system all over the world with special emphasis on India, Europe, and the United States. A note on other intellectual properties such as copyrights, trademarks, and designs is also added.
好奇的科学家们日复一日地进行着不懈且不间断的艰苦工作。在这个追求过程中，研究人员必须充分发挥他们的智力专长。最终，发明的所有功劳都归于发明者，发明者有权控制其智力创造。同样，制药公司花费大量资金从成千上万的先导化合物中成功推出一种新药。因此，每个公司都有特权保护其创新产品不被未经授权复制。当然，“专利”是这些医学智慧产品——药物的唯一守护者！本综述重点关注全球药物专利系统的各种复杂情况，特别强调印度、欧洲和美国。还添加了关于版权、商标和设计等其他知识产权的说明。
